Literature DB >> 31186870

Liver transplantation and nonalcoholic fatty liver disease.

Kymberly D Watt1.   

Abstract

Entities:  

Year:  2012        PMID： 31186870      PMCID： PMC6499279          DOI： 10.1002/cld.67

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


× No keyword cloud information.
  16 in total

1.  Laparoscopic Roux-en-Y gastric bypass is safe and feasible after orthotopic liver transplantation.

Authors:  David S Tichansky; Atul K Madan
Journal:  Obes Surg       Date:  2005 Nov-Dec       Impact factor: 4.129

2.  Intragastric balloon followed by biliopancreatic diversion in a liver transplant recipient: a case report.

Authors:  Paolo Gentileschi; Marco Venza; Domenico Benavoli; Francesca Lirosi; Ida Camperchioli; Marco D'Eletto; Alessandra Lazzaro; Vito M Stolfi; Alessandro Anselmo; Nicola Di Lorenzo; Giuseppe Tisone; Achille L Gaspari
Journal:  Obes Surg       Date:  2009-06-09       Impact factor: 4.129

3.  Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis.

Authors:  M J Contos; W Cales; R K Sterling; V A Luketic; M L Shiffman; A S Mills; R A Fisher; J Ham; A J Sanyal
Journal:  Liver Transpl       Date:  2001-04       Impact factor: 5.799

4.  Roux-en-Y gastric bypass for recurrent nonalcoholic steatohepatitis in liver transplant recipients with morbid obesity.

Authors:  A Duchini; M E Brunson
Journal:  Transplantation       Date:  2001-07-15       Impact factor: 4.939

5.  De novo nonalcoholic fatty liver disease after liver transplantation.

Authors:  Suk Seo; Kalyani Maganti; Manjit Khehra; Rajendra Ramsamooj; Alexander Tsodikov; Christopher Bowlus; John McVicar; Mark Zern; Natalie Torok
Journal:  Liver Transpl       Date:  2007-06       Impact factor: 5.799

6.  Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease.

Authors:  Kanthi Yalamanchili; Sherif Saadeh; Göran B Klintmalm; Linda W Jennings; Gary L Davis
Journal:  Liver Transpl       Date:  2010-04       Impact factor: 5.799

7.  Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver disease.

Authors:  Vishal Bhagat; Ayse L Mindikoglu; Carmine G Nudo; Eugene R Schiff; Andreas Tzakis; Arie Regev
Journal:  Liver Transpl       Date:  2009-12       Impact factor: 5.799

8.  Sleeve gastrectomy as treatment for severe obesity after orthotopic liver transplantation.

Authors:  Jean M Butte; Nicolás Devaud; Nicolás P Jarufe; Camilo Boza; Gustavo Pérez; Javiera Torres; Rosa M Pérez-Ayuso; Marco Arrese; Jorge Martínez
Journal:  Obes Surg       Date:  2007-11       Impact factor: 4.129

9.  Outcome after liver transplantation for NASH cirrhosis.

Authors:  S M Malik; M E deVera; P Fontes; O Shaikh; J Ahmad
Journal:  Am J Transplant       Date:  2009-04       Impact factor: 8.086

10.  Non-alcoholic fatty liver disease in liver transplant recipients: another story of "seed and soil".

Authors:  Jérôme Dumortier; Emiliano Giostra; Soraya Belbouab; Isabelle Morard; Olivier Guillaud; Laurent Spahr; Olivier Boillot; Laura Rubbia-Brandt; Jean-Yves Scoazec; Antoine Hadengue
Journal:  Am J Gastroenterol       Date:  2009-12-29       Impact factor: 10.864
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.